| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |